MedPath

A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus

Phase 2
Completed
Conditions
Diabetes Mellitus, Type 2
Interventions
Registration Number
NCT01071850
Lead Sponsor
Astellas Pharma Inc
Brief Summary

Evaluate the efficacy, safety, and tolerability of multiple doses of ASP1941 compared to placebo over 12 weeks of therapy in adult patients with type 2 diabetes mellitus.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
412
Inclusion Criteria
  • Subject has been diagnosed with type 2 diabetes
  • Subject has a HbA1c value between 6.8 and 9.5%
  • Subject has never, is not currently taking anti-diabetic medication OR is receiving a single anti- diabetic agent or low-doses two anti-diabetic medications and is willing to discontinue them during the study
  • Subject is on a stable diet and exercise program
  • Female subject is not pregnant and agrees to use an acceptable form of contraception throughout the duration of the study
Read More
Exclusion Criteria
  • Subject has type 1 diabetes mellitus
  • Subject is using insulin therapy
  • Subject has a serum creatinine higher than upper limit of normal
  • Subject has an ALT and/or AST value higher than 3 times upper limit of normal or a total bilirubin value more than 2 times upper limit of normal
  • Subject has persistent, uncontrolled severe hypertension as indicated by a

systolic blood pressure >180 mmHg or a diastolic blood pressure of

>110mmHg

  • Subject has had significant cardiovascular disease such as myocardial infarction or a vascular intervention (e.g., angioplasty or stent) in the last 3 months
  • Subject is known to have hepatitis or be a carrier of hepatitis B surface

antigen, hepatitis C virus antibody or is known positive for HIV1 and/or

HIV2

  • Subject has a history of lactic acidosis
  • Subject has a history of drug and alcohol abuse/dependency within last 12

months

  • Subject has had a malignancy in the last 5 years, except for successfully

treated basal or squamous cell carcinoma of the skin or of the cervix

  • Subject has a symptomatic urinary tract infection or genital infection
  • Female subject is lactating
  • Subject has an unstable medical or psychiatric illness
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ASP1941 lowest doseipragliflozinoral tablet
ASP1941 low doseipragliflozinoral tablet
ASP1941 high doseipragliflozinoral tablet
PlaceboPlacebooral tablet
ASP1941 highest doseipragliflozinoral tablet
MetforminMetforminoral tablet
Primary Outcome Measures
NameTimeMethod
Mean change from baseline in Hemoglobin A1c (HbA1c)12 weeks
Secondary Outcome Measures
NameTimeMethod
Proportion of subjects achieving target goal of HbA1c <7.0%12 weeks
Proportion of subjects achieving target goal of HbA1c <6.5%12 weeks
Mean change from baseline in fasting plasma glucose (FPG)12 weeks

Trial Locations

Locations (59)

CSRA Partners in Health, Inc.

๐Ÿ‡บ๐Ÿ‡ธ

Augusta, Georgia, United States

Atlanta Vascular Research Foundation, Atlanta Cardiology & Primary Care P.C.

๐Ÿ‡บ๐Ÿ‡ธ

Tucker, Georgia, United States

Bride, Bharti Hospital

๐Ÿ‡ฎ๐Ÿ‡ณ

Karnal, India

Diacon Hospital

๐Ÿ‡ฎ๐Ÿ‡ณ

Bangalore, India

Cedar Crosse Research Center

๐Ÿ‡บ๐Ÿ‡ธ

Chicago, Illinois, United States

Winston Technology Research, LLC

๐Ÿ‡บ๐Ÿ‡ธ

Haleyville, Alabama, United States

Desert Clinical Research

๐Ÿ‡บ๐Ÿ‡ธ

Mesa, Arizona, United States

Paul W. Davis, MD, PA

๐Ÿ‡บ๐Ÿ‡ธ

Pine Bluff, Arkansas, United States

Clinical Innovations, Inc.

๐Ÿ‡บ๐Ÿ‡ธ

Costa Mesa, California, United States

Expresscare Clinical Research

๐Ÿ‡บ๐Ÿ‡ธ

Colorado Springs, Colorado, United States

Torrance Clinical Research

๐Ÿ‡บ๐Ÿ‡ธ

Lomita, California, United States

Clinical Therapeutics Corp.

๐Ÿ‡บ๐Ÿ‡ธ

Coral Gables, Florida, United States

Del Rosario Medical Clinic, Inc

๐Ÿ‡บ๐Ÿ‡ธ

Huntington Park, California, United States

PAB Clinical Research

๐Ÿ‡บ๐Ÿ‡ธ

Brandon, Florida, United States

A.G.A Clinical Trials DBA Neostart Group

๐Ÿ‡บ๐Ÿ‡ธ

Hialeah, Florida, United States

Suncoast Clinical Research

๐Ÿ‡บ๐Ÿ‡ธ

New Port Richey, Florida, United States

APEX Medical Research, AMR, Inc

๐Ÿ‡บ๐Ÿ‡ธ

Chicago, Illinois, United States

MediSphere Medical Research

๐Ÿ‡บ๐Ÿ‡ธ

Evansville, Indiana, United States

Bay West Endocrinology

๐Ÿ‡บ๐Ÿ‡ธ

Towson, Maryland, United States

Prism Research

๐Ÿ‡บ๐Ÿ‡ธ

Saint Paul, Minnesota, United States

PMG Research of Salisbury, LLC

๐Ÿ‡บ๐Ÿ‡ธ

Salisbury, North Carolina, United States

PMG Research of Charlotte, LLC

๐Ÿ‡บ๐Ÿ‡ธ

Charlotte, North Carolina, United States

Integris Family Care

๐Ÿ‡บ๐Ÿ‡ธ

Yukon, Oklahoma, United States

Willamette Valley Clinical Studies

๐Ÿ‡บ๐Ÿ‡ธ

Eugene, Oregon, United States

Primecare of Southeastern Ohio, Inc.

๐Ÿ‡บ๐Ÿ‡ธ

Zanesville, Ohio, United States

PMG Research of Bristol, LLC

๐Ÿ‡บ๐Ÿ‡ธ

Bristol, Tennessee, United States

Fleetwood Clinical Research

๐Ÿ‡บ๐Ÿ‡ธ

Fleetwood, Pennsylvania, United States

Southeastern Research Associates, Inc.

๐Ÿ‡บ๐Ÿ‡ธ

Taylors, South Carolina, United States

Holston Medical Group

๐Ÿ‡บ๐Ÿ‡ธ

Kingsport, Tennessee, United States

Southwind Medical Specialist

๐Ÿ‡บ๐Ÿ‡ธ

Memphis, Tennessee, United States

Corpus Christi Family Wellness Center

๐Ÿ‡บ๐Ÿ‡ธ

Corpus Christi, Texas, United States

Punzi Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Carrollton, Texas, United States

Hormone Care and Research Centre

๐Ÿ‡ฎ๐Ÿ‡ณ

Ghaziabad, India

Fundacion de Caribe para le Investigacion Biomedica

๐Ÿ‡จ๐Ÿ‡ด

Barranquilla, Colombia

School of Medicine University of Rosario

๐Ÿ‡จ๐Ÿ‡ด

Bogota, Colombia

Centro de Reumatologia y ortopedia

๐Ÿ‡จ๐Ÿ‡ด

Barranquilla, Colombia

Aspen Clinical Research

๐Ÿ‡บ๐Ÿ‡ธ

Orem, Utah, United States

BIOMELAB

๐Ÿ‡จ๐Ÿ‡ด

Barranquilla, Colombia

Dexa Diad Servicios Medicos

๐Ÿ‡จ๐Ÿ‡ด

Bogota, Colombia

Fundacion Cardiovascular de Columbia

๐Ÿ‡จ๐Ÿ‡ด

Floridablanca Santander, Colombia

TOTALL Diabetes Hormone Institute Pvt.Ltd.

๐Ÿ‡ฎ๐Ÿ‡ณ

Indore, India

S R Kalla Memorial Gastro & General Hospital

๐Ÿ‡ฎ๐Ÿ‡ณ

Jaipur, India

Amrita Institute of Medical Sciences and Research Centre, AIMS

๐Ÿ‡ฎ๐Ÿ‡ณ

Kerala, India

Unidad Metabรณlica y Cardiovascular, SC.

๐Ÿ‡ฒ๐Ÿ‡ฝ

Cuernavaca, Mexico

Instituto Jaliscience de Investigacion Clinica

๐Ÿ‡ฒ๐Ÿ‡ฝ

Guadalajara, Mexico

Torre Medica Providencia

๐Ÿ‡ฒ๐Ÿ‡ฝ

Guadalajara, Mexico

Medical Care and Research

๐Ÿ‡ฒ๐Ÿ‡ฝ

Merida, Mexico

CEDIME, Instituto Vascular

๐Ÿ‡ฒ๐Ÿ‡ฝ

Merida, Mexico

Cebu Doctors' University Hospital

๐Ÿ‡ต๐Ÿ‡ญ

Cebu, Philippines

Hospital Universitario Dr. Eleuterio Gonzalez

๐Ÿ‡ฒ๐Ÿ‡ฝ

Monterrey, Mexico

St. Paul's Hospital

๐Ÿ‡ต๐Ÿ‡ญ

Iloilo City, Philippines

Amang Rodriguez Memorial Medical Center

๐Ÿ‡ต๐Ÿ‡ญ

Marikina City, Philippines

San Juan De Dios Hospital

๐Ÿ‡ต๐Ÿ‡ญ

Pasay City, Philippines

Parkway Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Birmingham, Alabama, United States

Central Phoenix Medical Clinic

๐Ÿ‡บ๐Ÿ‡ธ

Phoenix, Arizona, United States

San Diego Managed Care Group Clinical Research

๐Ÿ‡บ๐Ÿ‡ธ

San Diego, California, United States

Rapid Medical Research

๐Ÿ‡บ๐Ÿ‡ธ

Cleveland, Ohio, United States

Excel Clinical Research, LLC

๐Ÿ‡บ๐Ÿ‡ธ

Houston, Texas, United States

Cetero Research

๐Ÿ‡บ๐Ÿ‡ธ

San Antonio, Texas, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath